Bortezomib Sustains T Cell Function by Inducing miR-155-Mediated Downregulation of SOCS1 and SHIP1Ariana N. Renrick, Anil Shanker|Frontiers in Immunology|2021Cited by 43
Bortezomib enhances expression of effector molecules in anti-tumor CD8+ T lymphocytes by promoting Notch-nuclear factor-κB crosstalkMenaka C. Thounaojam, Anil Shanker|Oncotarget|2015Cited by 33